Color Doppler Ultrasonography in Evaluation of Active Sacroiliitis in Ankylosing Spondylitis

March 29, 2020 updated by: Hassan Salah Eldin Hassan Mohamed Elesseily, Assiut University

Role of Color Doppler Ultrasonography in Evaluation of Active Sacroiliitis in Ankylosing Spondylitis Patients and Its Relation With Disease Activity

Evaluate the role of color Doppler ultrasonography (CDUS) in detection of active sacroiliitis in Ankylosing Spondylitis patients using MRI of the sacroiliac joints as a gold standard.

Evaluate the relation of active sacroiliitis detected by color Doppler ultrasonography (CDUS) with disese activity in patients with ankylosing spondylitis

Study Overview

Detailed Description

Ankylosing spondylitis (AS) is the prototype of the spondyloarthropathies as a chronic inflammatory rheumatic disease presenting mainly with inflammation of the axial skeleton, peripheral arthritis, and enthesitis.

Sacroiliitis is an important sign of AS, and it is used to describe unilateral or bilateral involvement of the sacroiliac joint (SIJ) .

Early diagnosis of AS is important, since some changes associated with the disease are irreversible, and early diagnosis can also improve the ultimate clinical outcomes.

X-ray and magnetic resonance imaging (MRI) are frequently used as image tools to investigate sacroiliitis in AS patients. X-ray could show the structural lesion of sacroiliac joints (SIJs), but could not show the lesions in the early stage of disease. MRI can quantify active in¬flammatory lesions of SIJs.

However, MRI is relatively expensive and time-consuming, and its routine use in patient visits during ther¬apy would be difficult. Another factor that limits usage of MRI is that an important proportion of AS patients have prostheses. Therefore, an easier and cheaper method is needed to detect the degree of spinal inflammation.

Ultrasonography (US) is an inexpensive, non-invasive and non-radiating technique, which can be used in daily clinical practice .

Musculoskeletal ultrasonography (US) has gained increasing attention in many areas of rheumatology . In the area of spondyloarthropathy, Doppler US has been used frequently to assess enthesitis . It was demonstrated that signs of active sacroiliitis could be detected by the color Doppler ultrasonograpy (CDUS) method including increased vascularization in the posterior SIJ and a lower resistance index (RI). The RI could be a quantitative indicator of active sacroiliitis.

Treatment options to AS are limited and mainly consist of non-steroidal anti-inflammatory drugs (NSAIDs) and physical therapy .Efficacy of dis¬ease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate is uncertain to AS.

The introduction of biologic drugs for treatment of AS has led to effective treatment of disease symptoms and signs. However, the effect of these costly drugs on structural damage in addition to the clinical findings is not clear .

Study Type

Observational

Enrollment (Anticipated)

40

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients involved in the study will be recruited from outpatient clinics and inpatients of Rheumatology, Rehabilitation and Physical Medicine Department, Assiut University Hospitals, Faculty of Medicine.

Diagnosed as Ankylosing Spondylitis defined by the modified New York criteria , and classified as axial Spondyloarthritis according to Assessment in SpondyloArthritis International Society classification criteria

Description

Inclusion Criteria:

  • Age of patients (≥18 and ≤65 years old).
  • Diagnosed as Ankylosing Spondylitis defined by the modified New York criteria , and classified as axial Spondyloarthritis according to Assessment in SpondyloArthritis International Society classification criteria.

Exclusion Criteria:

  • Diseases mimicking as AS such as :

    • Flourosis of spine,
    • Diffuse idiopathic skeletal hyperostosis (DISH)
    • Degenerative spinal diseases (spondylosis deformans)
  • Other seronegative spondyloarthropathy :

    • Psoriatic arthritis ,
    • Reactive Arthritis,
    • Enteropathic Arthritis,
    • Undifferentiated spondyloarthropathy.
  • Other causes of sacroiliitis:

    • Osteoarthritis
    • Trauma
    • Infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
color Doppler ultrasonography (CDUS) in detection of active sacroiliitis in Ankylosing Spondylitis patients
Time Frame: two years
• Evaluate the role of color Doppler ultrasonography (CDUS) in detection of active sacroiliitis in Ankylosing Spondylitis patients using MRI of the sacroiliac joints as a gold standard
two years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2020

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

May 1, 2022

Study Registration Dates

First Submitted

March 29, 2020

First Submitted That Met QC Criteria

March 29, 2020

First Posted (Actual)

April 1, 2020

Study Record Updates

Last Update Posted (Actual)

April 1, 2020

Last Update Submitted That Met QC Criteria

March 29, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Active Sacroiliitis in Ankylosing Spondylitis

3
Subscribe